Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Adjuvant Capital was founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz and is based in New York.
Website:adjuvantcapital.com
Industries:
Biotechnology
Collaboration
Biopharma
Health Care
Medical
Genetics
Life Science
Medical Device
Therapeutics
Health Diagnostics
Consumer Goods
Manufacturing
Packaging Services
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Early Stage Venture
Location:
New York City, New York, United States
Contact information:
